NCT03220802View on ClinicalTrials.gov

Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 22, 2017

Primary Completion Date

July 17, 2018

Study Completion Date

September 30, 2020

Conditions
Patients on Long-term Proton Pump Inhibitor Therapy
Interventions
DIETARY_SUPPLEMENT

OMNI-BiOTiC PPI

The study product consists of a sachet containing 4g of yellowish powder made of corn starch, maltodextrin, fructo-oligosaccharide P6, inulin P2, vegetable protein and 12 bacterial strains (Bacillus coagulans W183, Bacillus subtilus W201, Bifidobacterium bifidum W23, Bifidobacterium lactis W52, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus acidophilus W22, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19, Propionibacterium freudenreichii W200, Lactobacillus rhamnosus W71, in a concentration of 2 x 109 cfu/g).

Trial Locations (1)

8010

Department of Internal Medicine, Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT03220802 - Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors | Biotech Hunter | Biotech Hunter